Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I. [electronic resource]
Producer: 19891208Description: 889-91 p. digitalISSN:- 0250-7005
- Adult
- Aged
- Arginine
- Breast Neoplasms -- drug therapy
- Colonic Neoplasms -- drug therapy
- Female
- Growth Hormone -- blood
- Humans
- Insulin-Like Growth Factor I -- analysis
- Kidney Neoplasms -- drug therapy
- Middle Aged
- Neoplasms -- drug therapy
- Octreotide -- therapeutic use
- Ovarian Neoplasms -- drug therapy
- Pancreatic Neoplasms -- drug therapy
- Somatomedins -- analysis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.